Painful Diabetic peripheral Neuropathy Study of Chinese OutPatiEnt (PDN-SCOPE): a multi-center cross-sectional registry study of clinical characteristics and treatment survey of PDN in China
Painful diabetic peripheral neuropathy (PDN) presents a serious health problem in China. SCOPE is a cross-sectional, multi-centers registry study with a target sample size of 1500 patients who are experiencing PDN. The patients are treated following guideline and local practice. Real-world data including demographics, medical histories, VAS, PHQ, GAD -7 and therapies are collected. The primary objective is to analyze the clinical characteristics of PDN. The secondary objectives include anxiety depression distribution and current treatment status.The SCOPE study will help to find actual clinical manifestation and treatment and improve the overall treatment outcome of Chinese patients with PDN.
Study Type
OBSERVATIONAL
Enrollment
1,500
Dongsheng Fan
Beijing, Beijing Municipality, China
RECRUITINGprevalnce of irrational use of pain reliever drugs
percent
Time frame: baseline
Douleur Neuropathique4 questions(DN4)
unit
Time frame: baseline
Visual Analogue Score(VAS)
1 to 10 units are minimum to maximum scores. Higher values represent a worse outcome of pain.
Time frame: baseline
Patient Health Questionnaire(PHQ-9)
0 to 27 units are minimum to maximum scores. Higher values represent a worse outcome of depression.
Time frame: baseline
Generalized Anxiety Disorder Screener (GAD-7)
0 to 21 units are minimum to maximum scores. Higher values represent a worse outcome of anxiety.
Time frame: baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.